middle-income countries – Talk Bio

Actionable Insights Powered by AI

GSK Licenses Experimental Shigella Vaccine to Bharat Biotech for Development and Distribution

1 month ago talkbio0Tagged Bharat, biotech, GMMA platform, low, Microbicides, middle-income countries, Resistance (Psychotherapeutic), Shigella Infections, Shigella Vaccines, SmithKline Beecham, vaccine licensing

GSK; Bharat Biotech; Shigella vaccine; altSonflex1-2-3; vaccine licensing; Shigellosis; GMMA platform; antimicrobial resistance; low and middle-income countries

Gilead Expands HIV Drug Access, Yet Faces Criticism Over Exclusion of Middle-Income Countries

10 months ago talkbio0Tagged Exclusion Criteria, Generic licensing agreements, Gilead Sciences, HIV Drug Access, HIV prevention, Lenacapavir, middle-income countries, Pre-exposure, Pre-Exposure Prophylaxis

Gilead Sciences, HIV drug access, Lenacapavir, Generic licensing agreements, Middle-income countries exclusion, HIV prevention, Pre-exposure prophylaxis (PrEP)